Jeremy Johnson

Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain

Jeremy Johnson, Mary Burnell-Nugent, Dominique Lossignol et al. · Journal of Pain and Symptom Management · 2009 · 619 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams‐Herman, Samuel S. Engel, Elizabeth Round et al. · BMC Endocrine Disorders · 2010 · 255 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

Jeremy Johnson, Dominique Lossignol, Mary Burnell-Nugent et al. · Journal of Pain and Symptom Management · 2012 · 232 citations

Medicine, Oncology, Pharmacology +17

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji et al. · Diabetes Obesity and Metabolism · 2017 · 164 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The <scp>VERTIS SITA2</scp> placebo‐controlled randomized study

Samuel Dagogo‐Jack, Jie Liu, Roy Eldor et al. · Diabetes Obesity and Metabolism · 2017 · 160 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11